Premium
Orgenesis Inc (EM) (ORGS)
USOTC
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produce... Orgenesis Inc., a biotech company, focuses on cell and gene therapies in the United States. It operates through two segments: Octomera and Therapies. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed cell based POCare therapies that are processed and produced under closed and automated POCare technology systems across a collaborative POCare model, POCare network consisting of research institutes and hospitals. Its therapies include autologous; cell-based immunotherapies; and therapeutics for metabolic diseases, anti-viral diseases, and tissue regeneration. It also provides hospital services and cell process development services. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is headquartered in Germantown, Maryland. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.095 | -16.1016949153 | 0.59 | 0.59 | 0.0031 | 212 | 0.28022191 | CS |
| 4 | 0.16225 | 48.7603305785 | 0.33275 | 0.845 | 0.001 | 2351 | 0.21313921 | CS |
| 12 | 0.095 | 23.75 | 0.4 | 0.845 | 0.001 | 1742 | 0.2921723 | CS |
| 26 | -0.255 | -34 | 0.75 | 0.845 | 0.001 | 1546 | 0.2517433 | CS |
| 52 | -1.355 | -73.2432432432 | 1.85 | 2.27 | 0.0001 | 1914 | 0.74440147 | CS |
| 156 | -8.765 | -94.6544276458 | 9.26 | 9.26 | 0.0001 | 6811 | 1.81804444 | CS |
| 260 | -8.765 | -94.6544276458 | 9.26 | 9.26 | 0.0001 | 6723 | 1.81804444 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
